Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells

Global Prevalence of Diabetes

Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · see citing works

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · see citing works

The mechanism of pancreatic secretion

Bayliss, W. M., & Starling, E. H. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000920 · Cited by 1,274 · see citing works

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

Xu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209 · see citing works

Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.

Jang, H.-J., Kokrashvili, Z., Theodorakis, M. J., Carlson, O. D., Kim, B.-J., Zhou, J., Kim, H. H., Xu, X., Chan, S. L., Juhaszova, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706890104 · Cited by 995 · cited 2× · see citing works

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., & Butler, P. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.018 · Cited by 944 · see citing works

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 916 · see citing works

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906 · see citing works

The role of incretins in glucose homeostasis and diabetes treatment

Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · see citing works

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793 · see citing works

Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets

Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664 · cited 1× · see citing works

Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor

Thorens, B., Porret, A., Bühler, L. H., Deng, S., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 552 · see citing works

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats

Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502 · see citing works

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Butler, A. E., Campbell-Thompson, M., Gurlo, T., Dawson, D. W., Atkinson, M., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1686 · Cited by 457 · see citing works

Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion*

Rocca, A. S., & Brubaker, P. L. (1999) · Endocrinology · doi:10.1210/endo.140.4.6643 · Cited by 452 · see citing works

Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats

Perfetti, R., Zhou, J., Doyle, M. E., & Egan, J. M. (2000) · Endocrinology · doi:10.1210/endo.141.12.7806 · Cited by 442 · see citing works

Glucagon-Like Peptide 1 Induces Pancreatic β-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor

Buteau, J., Foisy, S., Joly, E., & Prentki, M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.124 · Cited by 411 · see citing works

Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs

de Rooij, J., Rehmann, H., van Triest, M. H., Cool, R. H., Wittinghofer, A., & Bos, J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001113200 · Cited by 398 · see citing works

A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line

Gribble, F. M., Williams, L., Simpson, A. K., & Reimann, F. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1147 · Cited by 394 · see citing works

Glucagon-Like Peptide-1 and Exendin-4 Stimulate β-Cell Neogenesis in Streptozotocin-Treated Newborn Rats Resulting in Persistently Improved Glucose Homeostasis at Adult Age

Tourrel‐Cuzin, C., Bailbé, D., Meile, M.-J., Kergoat, M., & Portha, B. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1562 · Cited by 361 · see citing works

A Gastric Inhibitory Polypeptide II: The Complete Amino Acid Sequence

Brown, J. C., & Dryburgh, J. R. (1971) · Canadian Journal of Biochemistry · doi:10.1139/o71-122 · Cited by 344 · see citing works

Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation

Liu, Z., & Habener, J. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706105200 · Cited by 323 · see citing works

Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.

Zhou, J., Wang, X., Piñeyro, M. A., & Egan, J. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2358 · Cited by 319 · see citing works

Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5′-Adenosine Monophosphate-Dependent Protein Kinase A- and a Phosphatidylinositol 3-Kinase-Dependent Pathway

Hui, H., Nourparvar, A., Zhao, X., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2002-220897 · Cited by 307 · see citing works

Modulation of taste sensitivity by GLP‐1 signaling

Shin, Y., Martin, B., Golden, E. J., Dotson, C. D., Maudsley, S. R., Kim, W., Jang, H.-J., Mattson, M. P., Drucker, D. J., Egan, J. M., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05397.x · Cited by 287 · see citing works

Glucagon gene expression in vertebrate brain.

Drucker, D. J., & Asa, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68261-4 · Cited by 265 · see citing works

Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model

Gier, B., Matveyenko, A. V., Kirakossian, D., Dawson, D., Dry, S. M., & Butler, P. C. (2012) · Diabetes · doi:10.2337/db11-1109 · Cited by 255 · see citing works

Protein Kinase Cζ Activation Mediates Glucagon-Like Peptide-1–Induced Pancreatic β-Cell Proliferation

Buteau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252 · see citing works

Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells

Moens, K., Heimberg, H., Flamez, D., Huypens, P., Quartier, E., Ling, Z., Pipeleers, D., Gremlich, S., Thorens, B., & Schuit, F. (1996) · Diabetes · doi:10.2337/diab.45.2.257 · Cited by 250 · see citing works

β-Cell Pdx1 Expression Is Essential for the Glucoregulatory, Proliferative, and Cytoprotective Actions of Glucagon-Like Peptide-1

Li, Y., Cao, X., Li, L., Brubaker, P. L., Edlund, H., & Drucker, D. J. (2005) · Diabetes · doi:10.2337/diabetes.54.2.482 · Cited by 247 · see citing works

Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes

Matveyenko, A. V., Dry, S., Cox, H. I., Moshtaghian, A., Gurlo, T., Galasso, R., Butler, A. E., & Butler, P. C. (2009) · Diabetes · doi:10.2337/db09-0058 · Cited by 243 · see citing works

Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes

Bunck, M. C., Cornér, A., Eliasson, B., Heine, R. J., Shaginian, R. M., Taskinen, M.-R., Smith, U., Yki-Järvinen, H., & Diamant, M. (2011) · Diabetes Care · doi:10.2337/dc11-0291 · Cited by 240 · see citing works

Glucagon-Like Peptide 1 Induces Differentiation of Islet Duodenal Homeobox-1–Positive Pancreatic Ductal Cells Into Insulin-Secreting Cells

Hui, H., Wright, C. V. E., & Perfetti, R. (2001) · Diabetes · doi:10.2337/diabetes.50.4.785 · Cited by 224 · see citing works

Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Lipotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunB

Cunha, D. A., Ladrière, L., Ortis, F., Igoillo‐Esteve, M., Gurzov, E. N., Lupi, R., Marchetti, P., Eizirik, D. L., & Cnop, M. (2009) · Diabetes · doi:10.2337/db09-0685 · Cited by 222 · see citing works

Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells

Wang, Q., Li, L., Xu, E., Wong, V. S. C., Rhodes, C. J., & Brubaker, P. L. (2004) · Diabetologia · doi:10.1007/s00125-004-1327-5 · Cited by 207 · see citing works

Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function

Park, S., Dong, X. C., Fisher, T. L., Dunn, S., Omer, A., Weir, G. C., & White, M. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508307200 · Cited by 207 · see citing works

Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes

Meier, J., Lin, J. C., Butler, A., Galasso, R., Martinez, D., & Butler, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0308-2 · Cited by 192 · see citing works

GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a β-Arrestin 1-mediated ERK1/2 Activation in Pancreatic β-Cells

Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E. M., Bockaert, J., Bertrand, G., & Dalle, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.067207 · Cited by 187 · see citing works

A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer

Alves, C., Batel-Marques, F., & Macedo, A. F. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.008 · Cited by 186 · see citing works

Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide

Kolligs, F. T., Fehmann, H.-C., Göke, R., & Göke, B. (1995) · Diabetes · doi:10.2337/diab.44.1.16 · Cited by 185 · see citing works

Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice

Suarez‐Pinzon, W. L., Power, R. F., Yan, Y., Wasserfall, C. H., Atkinson, M. A., & Rabinovitch, A. (2008) · Diabetes · doi:10.2337/db08-0688 · Cited by 182 · see citing works

Insulinotropic Glucagon-Like Peptide I Receptor Expression in Glucagon-Producing α-Cells of the Rat Endocrine Pancreas

Heller, R. S., Kieffer, T. J., & Habener, J. F. (1997) · Diabetes · doi:10.2337/diab.46.5.785 · Cited by 179 · see citing works

Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass

Buteau, J., Spatz, M. L., & Accili, D. (2006) · Diabetes · doi:10.2337/db05-0825 · Cited by 178 · see citing works

Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?

Whalley, N., Pritchard, L. E., Smith, D. M., & White, A. E. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0094 · Cited by 178 · see citing works

Role of Endogenous Glucagon-Like Peptide-1 in Islet Regeneration After Partial Pancreatectomy

León, D. D. D., Deng, S., Madani, R., Ahima, R. S., Drucker, D. J., & Stoffers, D. A. (2003) · Diabetes · doi:10.2337/diabetes.52.2.365 · Cited by 172 · see citing works

Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats

Nie, Y., Nakashima, M., Brubaker, P. L., Li, Q., Perfetti, R., Jansen, E., Zambre, Y., PIPELEERS, D. G., & Friedman, T. C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7456 · Cited by 170 · see citing works

Exendin-4 Improves Reversal of Diabetes in NOD Mice Treated with Anti-CD3 Monoclonal Antibody by Enhancing Recovery of β-Cells

Sherry, N. A., Chen, W., Kushner, J. A., Glandt, M., Tang, Q., Tsai, S., Santamaria, P., Bluestone, J. A., Brillantes, A.-M. B., & Herold, K. C. (2007) · Endocrinology · doi:10.1210/en.2007-0358 · Cited by 169 · see citing works

Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4

Ogawa, N., List, J. F., Habener, J. F., & Maki, T. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1700 · Cited by 156 · see citing works

Exendin-4 Protects β-Cells From Interleukin-1β–Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway

Ferdaoussi, M., Abdelli, S., Yang, J.-Y., Cornu, M., Niederhauser, G., Favre, D., Widmann, C., Regazzi, R., Thorens, B., Waeber, G., et al. (2008) · Diabetes · doi:10.2337/db07-1214 · Cited by 153 · see citing works

Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways

Friedrichsen, B. N., Neubauer, N., Lee, Y. C., Gram, V. K., Blume, N., Petersen, J. S., Nielsen, J. H., & Møldrup, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06160 · Cited by 147 · see citing works

Regulation of glucagon secretion by incretins

Holst, J. J., Christensen, M., Lund, A., de Heer, J., Svendsen, B., Kielgast, U. L., & Knop, F. K. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01452.x · Cited by 143 · see citing works

Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation

Scopsi, L., Gullo, M., Rilke, F. O., Martin, S., & Steiner, D. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829629 · Cited by 141 · see citing works

Effects of exenatide alone and in combination with daclizumab on β-cell function in long-standing type 1 diabetes

Rother, K. I., Spain, L. M., Wesley, R. A., Digon, B. J., Baron, A., Chen, K., Nelson, P., Dosch, H.-M., Palmer, J. P., Brooks-Worrell, B., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0773 · Cited by 133 · see citing works

Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.

Skoglund, G., Hussain, M. A., & Holz, G. G. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1156 · Cited by 127 · see citing works

The Human GLP-1 Analog Liraglutide and the Pancreas

Nyborg, N. C. B., Mølck, A.-M., Madsen, L. W., & Bjerre Knudsen, L. (2012) · Diabetes · doi:10.2337/db11-0936 · Cited by 125 · see citing works

Glucagon-Like Peptide I and Glucose-Dependent Insulinotropic Polypeptide Stimulate Ca2+-Induced Secretion in Rat α-Cells by a Protein Kinase A–Mediated Mechanism

Ding, W., Renström, E., Rorsman, P., Buschard, K., & Gromada, J. (1997) · Diabetes · doi:10.2337/diab.46.5.792 · Cited by 120 · see citing works

NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1

Lawrence, M. C., Bhatt, H. S., & Easom, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.3.691 · Cited by 115 · see citing works

Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.

Scrocchi, L. A., Marshall, B. A., Cook, S., Brubaker, P. L., & Drucker, D. J. (1998) · Diabetes · doi:10.2337/diabetes.47.4.632 · Cited by 114 · see citing works

Ontogeny of Regeneration of β-Cells in the Neonatal Rat after Treatment with Streptozotocin

Thyssen, S. M., Arany, E. J., & Hill, D. J. (2006) · Endocrinology · doi:10.1210/en.2005-0396 · Cited by 113 · see citing works

Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice

Xavier, G. D. S., Mondragon, A., Sun, G., Chen, L., McGinty, J., French, P. M. W., & Rutter, G. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2600-7 · Cited by 108 · see citing works

Exendin 4 Up-Regulates Expression of PDX 1 and Hastens Differentiation and Maturation of Human Fetal Pancreatic Cells

Movassat, J., Beattie, G. M., Lopez, A. D., & Hayek, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020137 · Cited by 104 · see citing works

GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways

Aronis, K. N., Chamberland, J. P., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.04.010 · Cited by 104 · see citing works

The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway

Miao, X., Gu, Z., Liu, P., Hu, Y., Li, L., Gong, Y., Shu, H., Liu, Y., & Li, C. (2012) · Peptides · doi:10.1016/j.peptides.2012.10.006 · Cited by 103 · see citing works

Exendin‐4 differentiation of a human pancreatic duct cell line into endocrine cells: Involvement of PDX‐1 and HNF3β transcription factors

Zhou, J., Piñeyro, M. A., Wang, X., Doyle, M. E., & Egan, J. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10143 · Cited by 95 · see citing works

Exenatide inhibits β-cell apoptosis by decreasing thioredoxin-interacting protein

Chen, J., Couto, F. M., Minn, A. H., & Shalev, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.027 · Cited by 94 · see citing works

Glucagon-like Peptide-1 Increases β-Cell Glucose Competence and Proliferation by Translational Induction of Insulin-like Growth Factor-1 Receptor Expression

Cornu, M., Modi, H., Kawamori, D., Kulkarni, R., Joffraud, M., & Thorens, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091116 · Cited by 92 · see citing works

Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion

Rocca, A. S. (1999) · Endocrinology · doi:10.1210/en.140.4.1687 · Cited by 91 · see citing works

Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells

Wang, Y., Egan, J., Raygada, M. J., Nadiv, O., Roth, J., & Montrose‐Rafizadeh, C. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588224 · Cited by 88 · see citing works

A Review of Types 1 and 2 Diabetes Mellitus and Their Treatment with Insulin

Salsali, A., & Nathan, M. (2006) · American Journal of Therapeutics · doi:10.1097/00045391-200607000-00012 · Cited by 85 · see citing works

Enhanced expression of PDX-1 and Ngn3 by exendin-4 during β cell regeneration in STZ-treated mice

Kodama, S., Toyonaga, T., Kondo, T., Matsumoto, K., Tsuruzoe, K., Kawashima, J., Goto, H., Kume, K., Kume, S., Sakakida, M., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.120 · Cited by 84 · see citing works

Anti-proliferative effect of pro-inflammatory cytokines in cultured β cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1

Blandino-Rosano, M., Perez-Arana, G., Mellado-Gil, J. M., Segundo, C., & Aguilar-Diosdado, M. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0154 · Cited by 82 · see citing works

Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells

Wang, H., Iezzi, M., Theander, S. S., Antinozzi, P. A., Gauthier, B. R., Halban, P. A., & Wollheim, C. B. (2005) · Diabetologia · doi:10.1007/s00125-005-1692-8 · Cited by 79 · see citing works

Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans

Meier, J. J., Butler, A. E., Galasso, R., RIZZA, R. A., & Butler, P. C. (2006) · Diabetologia · doi:10.1007/s00125-006-0410-5 · Cited by 71 · see citing works

A Switch From Prohormone Convertase (PC)-2 to PC1/3 Expression in Transplanted α-Cells Is Accompanied by Differential Processing of Proglucagon and Improved Glucose Homeostasis in Mice

Wideman, R. D., Covey, S. D., Webb, G. C., Drucker, D. J., & Kieffer, T. J. (2007) · Diabetes · doi:10.2337/db07-0563 · Cited by 70 · see citing works

Combination Therapy with Glucagon-Like Peptide-1 and Gastrin Induces β-Cell Neogenesis from Pancreatic Duct Cells in Human Islets Transplanted in Immunodeficient Diabetic Mice

Suarez‐Pinzon, W. L., Lakey, J. R. T., & Rabinovitch, A. (2008) · Cell Transplantation · doi:10.3727/096368908786092775 · Cited by 65 · see citing works

Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth

Nishioka, T., Kim, H., Luo, L.-Y., Huang, Y., Guo, J., & Chen, C. Y. (2011) · Breast Cancer Research · doi:10.1186/bcr3055 · Cited by 65 · see citing works

Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways

Nishizawa, M., Nakabayashi, H., Uehara, K., Nakagawa, A., Uchida, K., & Koya, D. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00565.2012 · Cited by 64 · see citing works

Human embryonic stem cell differentiation into insulin secreting β‐cells for diabetes

Bose, B., Shenoy, S., Konda, S., & Wangikar, P. (2012) · Cell Biology International · doi:10.1042/cbi20120210 · Cited by 62 · see citing works

Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients

Pugazhenthi, U., Velmurugan, K., Tran, A., Mahaffey, G., & Pugazhenthi, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1849-y · Cited by 61 · see citing works

Exchange protein activated by cAMP 1 (Epac1) ‐deficient mice develop β‐cell dysfunction and metabolic syndrome

Kai, A. K. L., Lam, A. K. M., Chen, Y., Tai, A. C. P., Zhang, X., Lai, A. K. W., Yeung, P. K. K., Tam, S., Wang, J., Lam, K. S. L., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-230433 · Cited by 58 · see citing works

Are there pancreatic progenitor cells from which new islets form after birth?

Bonner-Weir, S., & Sharma, A. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0186 · Cited by 57 · see citing works

Glucose Dependence of the Regulated Secretory Pathway in αTC1-6 Cells

McGirr, R., Ejbick, C. E., Carter, D. E., Andrews, J. D., Nie, Y., Friedman, T. C., & Dhanvantari, S. (2005) · Endocrinology · doi:10.1210/en.2005-0402 · Cited by 55 · see citing works

Regenerating pancreatic β-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis

Juhl, K., Bonner‐Weir, S., & Sharma, A. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283344932 · Cited by 54 · see citing works

A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis

Cho, J. M., Jang, H. W., Cheon, H., Jeong, Y. T., Kim, D., Lim, Y.-M., Choi, S., Yang, E.-K., Shin, C.-Y., Son, M. H., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.10.012 · Cited by 51 · see citing works

Glucagon-Like Peptide-1 Enhances Glucokinase Activity in Pancreatic β-Cells through the Association of Epac2 with Rim2 and Rab3A

Park, J., Kim, S., Park, S.-H., Son, D., Bae, J., Kim, H. K., Han, J., & Song, D. (2011) · Endocrinology · doi:10.1210/en.2011-0259 · Cited by 49 · see citing works

Synapses of Amphids Defective (SAD-A) Kinase Promotes Glucose-stimulated Insulin Secretion through Activation of p21-activated Kinase (PAK1) in Pancreatic β-Cells

Nie, J., Sun, C., Faruque, O. M., Ye, G., Li, J., Liang, Q., Chang, Z., Yang, W., Han, X., & Shi, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.378372 · Cited by 45 · see citing works

Diabetes Outfoxed by GLP-1?

Holz, G. G., & Chepurny, O. G. (2005) · Science s STKE · doi:10.1126/stke.2682005pe2 · Cited by 45 · see citing works

Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration

Chen, S., Shimoda, M., Chen, J., Matsumoto, S., & Grayburn, P. A. (2012) · Cell Cycle · doi:10.4161/cc.11.4.19120 · Cited by 44 · see citing works

Prolonged Remission of Diabetes by Regeneration of β Cells in Diabetic Mice Treated with Recombinant Adenoviral Vector Expressing Glucagon-like Peptide-1

Liu, M.-J., Shin, S., Li, N., Shigihara, T., Lee, Y.-S., Yoon, J., & Jun, H. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300005 · Cited by 43 · see citing works

Exendin-4 inhibits glucolipotoxic ER stress in pancreatic β cells via regulation of SREBP1c and C/EBPβ transcription factors

Oh, Y. S., Lee, Y.-J., KANG, Y. Y., Han, J., Lim, O.-K., & Jun, H. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0311 · Cited by 41 · see citing works

Cross-talk between Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling Is Essential for Exendin-4-induced Insulin-positive Differentiation of AR42J Cells

Yew, K.-H., Hembree, M. J., Prasadan, K. L., Preuett, B. L., McFall, C. R., Benjes, C. L., Crowley, A. R., Sharp, S. W., Tulachan, S., Mehta, S. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505465200 · Cited by 39 · see citing works

Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation

Heller, C., Kühn, M. C., Mülders-Opgenoorth, B., Schott, M., Willenberg, H. S., Scherbaum, W. A., & Schinner, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2011 · Cited by 32 · see citing works

COUP-TFII Controls Mouse Pancreatic β-Cell Mass through GLP-1-β-Catenin Signaling Pathways

Boutant, M., Ramos, O. H. P., Tourrel‐Cuzin, C., Movassat, J., Ilias, A., Vallois, D., Planchais, J., Pégorier, J. P., Schuit, F. C., PETIT, P. X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030847 · Cited by 28 · see citing works

Glucagon Like Peptide-1-Directed Human Embryonic Stem Cells Differentiation Into Insulin-Producing Cells Via Hedgehog, cAMP, and PI3K Pathways

Hui, H., Tang, Y. G., Zhu, L., Khoury, N., Hui, J. Z., Wang, K. Y., Perfetti, R., & Go, V. L. W. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181bc30dd · Cited by 25 · see citing works

SAD-A Potentiates Glucose-Stimulated Insulin Secretion as a Mediator of Glucagon-Like Peptide 1 Response in Pancreatic β Cells

Nie, J., Lilley, B. N., Pan, Y. A., Faruque, O. M., Liu, X., Zhang, W., Sanes, J. R., Han, X., & Shi, Y. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00285-13 · Cited by 25 · see citing works

Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds

Cohen, D. (2013) · BMJ · doi:10.1136/bmj.f2607 · Cited by 24 · see citing works

B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic β-cells

Hwang, S., Kwon, O., Kim, S., Lee, I., & Kim, Y. D. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.47 · Cited by 23 · see citing works

Glucagon‐like peptide‐1 receptor expression in Xenopus oocytes stimulates inositol trisphosphate‐dependent intracellular Ca2+ mobilization

Gromada, J., Anker, C., Bokvist, K. B., Knudsen, L. B., & Wahl, P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00254-3 · Cited by 23 · see citing works

Erratum

(2012) · Diabetes · doi:10.2337/db12-er08 · Cited by 23 · see citing works

Synergistic Endocrine Induction by GLP-1 and TGF-?? in the Developing Pancreas

Tei, E., Mehta, S. S., Tulachan, S., Yew, H., Hembree, M. J., Preuett, B. L., Snyder, C. L., Yamataka, A., Miyano, T., & Gittes, G. K. (2005) · Pancreas · doi:10.1097/01.mpa.0000172566.70619.58 · Cited by 18 · see citing works

The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats

Dağıstanlı, F. K., & Öztürk, M. (2013) · Acta Histochemica · doi:10.1016/j.acthis.2012.12.007 · Cited by 16 · see citing works

In Vivo Regeneration of Insulin-Producing β-Cells

Jun, H. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_27 · Cited by 15 · see citing works

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 503 · see citing works

Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation

Raheem, A., Liang, L., Zhang, G., & Cui, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616713 · Cited by 315 · see citing works

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales

Dahlén, A. D., Dashi, G., Maslov, I. O., Attwood, M. M., Jonsson, J., Trukhan, V., & Schiöth, H. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.807548 · Cited by 280 · see citing works

Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice

Wang, Y., Dilidaxi, D., Wu, Y., Sailike, J., Sun, X., & Nabi, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109914 · Cited by 277 · see citing works

Mechanisms of the anorexia of aging—a review

Wysokiński, A., Sobów, T., Kłoszewska, I., & Kostka, T. (2015) · AGE · doi:10.1007/s11357-015-9821-x · Cited by 245 · see citing works

Semaglutide for the treatment of obesity

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.12.008 · Cited by 227 · see citing works

TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook

Alhawiti, N. M., Mahri, S. A., Aziz, M. A., Malik, S. S., & Mohammad, S. (2017) · Current Drug Targets · doi:10.2174/1389450118666170130145514 · Cited by 220 · see citing works

The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect

Makrilakis, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152720 · Cited by 225 · see citing works

Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling

Oh, Y., & Jun, H.-S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010026 · Cited by 217 · see citing works

Regulation of Bim in Health and Disease

Sionov, R. V., Vlahopoulos, S., & Granot, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.5492 · Cited by 225 · see citing works

Pharmacotherapy of type 2 diabetes: An update and future directions

DeMarsilis, A. J., Reddy, N., Boutari, C., Filippaios, A., Sternthal, E., Katsiki, N., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155332 · Cited by 161 · see citing works

Current and future therapies for type 1 diabetes

von Scholten, B. J., Kreiner, F. F., Gough, S. C. L., & von Herrath, M. (2021) · Diabetologia · doi:10.1007/s00125-021-05398-3 · Cited by 148 · see citing works

Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease

Badawi, G. A., Fattah, M. A. A. E., Zaki, H. F., & Sayed, M. I. E. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0331-6 · Cited by 123 · see citing works

Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation

Lee, Y.-S., Lee, C., Choung, J.-S., Jung, H.-S., & Jun, H.-S. (2018) · Diabetes · doi:10.2337/db18-0155 · Cited by 114 · see citing works

Protection against cardiac hypertrophy by geniposide involves the GLP‐1 receptor / AMPKα signalling pathway

Ma, Z., Dai, J., Zhang, W., Yuan, Y., Liao, H., Zhang, N., Bian, Z., & Tang, Q. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13449 · Cited by 109 · see citing works

Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing

Seo, E., Lim, J. S., Jun, J.-B., Choi, W., Hong, I., & Jun, H. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1145-4 · Cited by 108 · see citing works

A review of gliptins for 2014

Scheen, A. J. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.978289 · Cited by 104 · see citing works

Age- and diet-specific effects of chronic exposure to chlorpyrifos on hormones, inflammation and gut microbiota in rats

Li, J., Fang, B., Pang, G., Zhang, M., & Ren, F. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.05.018 · Cited by 104 · see citing works

B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy

Alam, M., Ali, S., Mohammad, T., Hasan, G. M., Yadav, D. K., & Hassan, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910442 · Cited by 97 · see citing works

Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies

Mesinovic, J., Fyfe, J. J., Talevski, J., Wheeler, M. J., Leung, G. K. W., George, E. S., Hunegnaw, M. T., Glavas, C., Jansons, P., Daly, R. M., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0112 · Cited by 95 · see citing works

Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs—A mechanistic revisit to understand their mode of action

Gupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 90 · see citing works

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Lee, S., & Lee, D. Y. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.1.15 · Cited by 79 · see citing works

COUP-TFII in Health and Disease

Polvani, S., Pepe, S., Milani, S., & Galli, A. (2019) · Cells · doi:10.3390/cells9010101 · Cited by 76 · see citing works

Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators

Bedinger, D., & Adams, S. H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.013 · Cited by 80 · see citing works

Metabolic and cardiovascular benefits of GLP‑1 agonists, besides the hypoglycemic effect (Review)

Iorga, R., Bacalbașa, N., Carşote, M., Bratu, O. G., Stănescu, A. M. A., BUNGAU, S. G., Pantiș, C., & Diaconu, C. C. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8714 · Cited by 79 · see citing works

Gastrointestinal actions of glucagon‐like peptide‐1‐based therapies: glycaemic control beyond the pancreas

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Cahen, D. L., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12593 · Cited by 74 · see citing works

Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway

Thompson, A., & Kanamarlapudi, V. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.015 · Cited by 74 · see citing works

Recent advances of dicyano-based materials in biology and medicine

Zhang, W., Huo, F., & Yin, C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02205d · Cited by 71 · see citing works

Spotlight on the Mechanism of Action of Semaglutide

Papakonstantinou, I. P., Tsioufis, K. P., & Katsi, V. K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120872 · Cited by 80 · see citing works

Glucagon-like peptide 1 analogues as adjunctive therapy for patients with type 1 diabetes: An updated systematic review and meta-analysis

Park, J., Ntelis, S., Yunasan, E., Downton, K. D., Yip, T. C.-F., Munir, K. M., & Haq, N. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad471 · Cited by 69 · see citing works

DPP-4 inhibitors: focus on safety

Tella, S. H., & Rendell, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.977863 · Cited by 63 · see citing works

The role of selenium in insulin resistance

Fontenelle, L. C., Feitosa, M. M., Morais, J. B. S., Severo, J. S., de Freitas, T. E. C., Beserra, J. B., Henriques, G. S., & Marreiro, D. D. N. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000100139 · Cited by 62 · see citing works

A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents.

Tegegne, B. A., Adugna, A., Yenet, A., Yihunie Belay, W., Yibeltal, Y., Dagne, A., Hibstu Teffera, Z., Amare, G. A., Abebaw, D., Tewabe, H., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1440456 · Cited by 61 · see citing works

Rye-Based Evening Meals Favorably Affected Glucose Regulation and Appetite Variables at the Following Breakfast; A Randomized Controlled Study in Healthy Subjects

Sandberg, J. C., Björck, I., & Nilsson, A. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151985 · Cited by 60 · see citing works

Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals

Liu, T., Ning, J., Wang, B., Dong, B., Li, S., Tian, X., Yu, Z., Peng, Y., Wang, C., Zhao, X., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04957 · Cited by 57 · see citing works

Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios

Peralta, F. G., Abreu, C., Rodríguez, S. G., Barranco, R. J., & Umpierrez, G. E. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0488-z · Cited by 59 · see citing works

Exenatide regulates Th17/Treg balance via PI3K/Akt/FoxO1 pathway in db/db mice

Xu, Q., Zhang, X., Li, T., & Shao, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00574-6 · Cited by 59 · see citing works

Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells

Li, Z., Ni, C.-L., Yao, Z., Chen, L.-M., & Niu, W.-Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.008 · Cited by 56 · see citing works

Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity

Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56 · see citing works

Trace amine–associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells

Michael, E. S., Covic, L., & Kuliopulos, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005464 · Cited by 56 · see citing works

Effects of Diethyl Phosphate, a Non-Specific Metabolite of Organophosphorus Pesticides, on Serum Lipid, Hormones, Inflammation, and Gut Microbiota

Yang, F., Li, J., Pang, G., Ren, F., & Fang, B. (2019) · Molecules · doi:10.3390/molecules24102003 · Cited by 55 · see citing works

The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder

Xu, L., Lu, Y., Wang, N., & Feng, Y. (2022) · Antioxidants · doi:10.3390/antiox11050922 · Cited by 53 · see citing works

Tetrahydrocurcumin ameliorates diabetes profiles of db/db mice by altering the composition of gut microbiota and up-regulating the expression of GLP-1 in the pancreas

Yuan, T., Yin, Z., Yan, Z., Hao, Q., Zeng, J., Li, L., & Zhao, J. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104665 · Cited by 51 · see citing works

Obesity, Heart Failure with Preserved Ejection Fraction, and the Role of Glucagon-Like Peptide-1 Receptor Agonists

Cimino, G., Vaduganathan, M., Lombardi, C., Pagnesi, M., Vizzardi, E., Tomasoni, D., Adamo, M., Metra, M., & Inciardi, R. M. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14560 · Cited by 59 · see citing works

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice

Wei, T., Cui, X., Jiang, Y., Wang, K., Wang, D., Li, F., Lin, X., Gu, L., Yang, K., Yang, J., et al. (2023) · Diabetes · doi:10.2337/db22-0784 · Cited by 50 · see citing works

Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms

Musaimi, O. A. (2024) · Biomolecules · doi:10.3390/biom14030264 · Cited by 50 · see citing works

The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs

Zhan, J., Wang, Y., Wang, Y., Tang, Z.-Y., Tan, P., Huang, W., & Liu, Y. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.086 · Cited by 50 · see citing works

An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers

Tseng, C.-H., Lee, K.-Y., & Tseng, F.-H. (2015) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590501.2015.1003496 · Cited by 49 · see citing works

Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes

Imbroane, M. R., LeMoine, F., & Nau, C. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.01.019 · Cited by 49 · see citing works

Exendin-4 enhances the differentiation of Wharton’s jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers

Kassem, D., Kamal, M. M., El-Kholy, A., & El-Mesallamy, H. (2016) · Stem cell research & therapeutics · doi:10.1186/s13287-016-0374-4 · Cited by 43 · see citing works

Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice

Liu, W., Son, D. O., Lau, H., Zhou, Y., Prud’homme, G. J., Jin, T., & Wang, Q. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00362 · Cited by 50 · see citing works

Cellular signaling pathways regulating β‑cell proliferation as a promising therapeutic target in the treatment of diabetes (Review)

Jiang, W., Peng, Y., & Yang, K. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6603 · Cited by 49 · see citing works

GLP-1 Receptor: A New Target for Sepsis

Yang, F., Zeng, F., Luo, X., Lei, Y., Li, J., Lu, S., Huang, X., Lan, Y., & Liu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.706908 · Cited by 48 · see citing works

Compare And Contrast the Glucagon-like Peptide-1 Receptor Agonists (GLP1RAs)

Latif, W. A., Lambrinos, K. J., & Rodríguez, R. (2021) · StatPearls · Cited by 47 · see citing works

TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients

Borowiec, A. M., Właszczuk, A., Olakowska, E., & Lewin‐Kowalik, J. (2022) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2187 · Cited by 46 · see citing works

Investigational insulin secretagogues for type 2 diabetes

Scheen, A. J. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1152260 · Cited by 48 · see citing works

The effects of incretin‐based therapies on β‐cell function and insulin resistance in type 2 diabetes: A systematic review and network meta‐analysis combining 360 trials

Wu, S., Gao, L., Cipriani, A., Huang, Y., Yang, Z., Yang, J., Yu, S., Zhang, Y., Chai, S., Zhang, Z., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13613 · Cited by 47 · see citing works

Recent advances in medicinal and edible homologous plant polysaccharides: Preparation, structure and prevention and treatment of diabetes

Li, L., Xie, J., Zhang, Z., Xia, B., Li, Y., Lin, Y., Li, M., Wu, P., & Lin, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128873 · Cited by 44 · see citing works

Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells

Maffei, A., Segal, A. M., Álvarez-Pérez, J. C., Garcı́a-Ocaña, A., & Harris, P. E. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1273 · Cited by 47 · see citing works

Glucagon-like peptide-1 production in the GLUTag cell line is impaired by free fatty acids via endoplasmic reticulum stress

Hayashi, H., Yamada, R., Das, S., Sato, T., Takahashi, A., Hiratsuka, M., & Hirasawa, N. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.012 · Cited by 45 · see citing works

Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy

Conlon, J. M., Mechkarska, M., Abdel‐Wahab, Y. H. A., & Flatt, P. R. (2017) · Peptides · doi:10.1016/j.peptides.2017.09.001 · Cited by 43 · see citing works

A 2021 Update on the Use of Liraglutide in the Modern Treatment of ‘Diabesity’: A Narrative Review

Tilinca, M. C., Tiucă, R. A., Burlacu, A., & Varga, A. (2021) · Medicina · doi:10.3390/medicina57070669 · Cited by 43 · see citing works

Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis

Zummo, F. P., Krishnanda, S. I., Georgiou, M., O'Harte, F. P. M., Parthsarathy, V., Cullen, K. S., Honkanen‐Scott, M., Shaw, J., Lovat, P. E., & Arden, C. (2021) · Autophagy · doi:10.1080/15548627.2021.1956123 · Cited by 43 · see citing works

GLP-1R Signaling and Functional Molecules in Incretin Therapy

Wan, W., Qin, Q., Xie, L., Zhang, H., Wu, F., Stevens, R. C., & Liu, Y. (2023) · Molecules · doi:10.3390/molecules28020751 · Cited by 44 · see citing works

A new hypoglycemic mechanism of catalpol revealed by enhancing MyoD/MyoG-mediated myogenesis

Xu, D., Wang, L., Jiang, Z., Zhao, G., Hassan, H. M., Sun, L., Fan, S., Zhou, Z., Zhang, L., & Wang, T. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.028 · Cited by 42 · see citing works

Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects

Tanaka, M., Matsuo, Y., Yamakage, H., Masuda, S., Terada, Y., Muranaka, K., Wada, H., Hasegawa, K., Shimatsu, A., & Satoh‐Asahara, N. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.009 · Cited by 41 · see citing works

Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats

Hamza, A. A., Fikry, E. M., Hassan, W. A., & Amin, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28029-1 · Cited by 41 · see citing works

Perioperative Management of Patients Taking Glucagon-like Peptide-1 Receptor Agonists: Applying Evidence to Clinical Practice

Oprea, A. D., Umpierrez, G. E., Sweitzer, B., & Hepner, D. L. (2024) · Anesthesiology · doi:10.1097/aln.0000000000005204 · Cited by 40 · see citing works

Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway

Zhan, J., Tan, P., Wang, Y., Wang, Y., He, J., Tang, Z.-Y., Huang, W., & Liu, Y. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-6481332511368690 · Cited by 39 · see citing works

Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases

Yang, F., Luo, X., Li, J., Yu, L., Zeng, F., Huang, X., Lan, Y., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113236 · Cited by 38 · see citing works

Reply to the Comment on: Subrat Khanal et al. The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly. Biomedicines 2018, 6, 30

Khanal, S., Ghimire, P., & Dhamoon, A. S. (2019) · Biomedicines · doi:10.3390/biomedicines7010010 · Cited by 38 · see citing works

The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study

Ayoub, M., Faris, C., Juranovic, T., Chela, H. K., & Daglilar, E. S. (2024) · Cancers · doi:10.3390/cancers16091625 · Cited by 37 · see citing works

Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels

Capuccio, S., Scilletta, S., Rocca, F. L., Miano, N., Marco, M. D., Bosco, G., Barbagallo, F. D. G., Scicali, R., Piro, S., & Pino, A. D. (2024) · Biomolecules · doi:10.3390/biom14060687 · Cited by 37 · see citing works

Beneficial effects of psyllium on the prevention and treatment of cardiometabolic diseases

Chen, C., Shang, C., Xin, L., Xiang, M., Wang, Y., Shen, Z., Jiao, L., Ding, F., & Cui, X. (2022) · Food & Function · doi:10.1039/d2fo00560c · Cited by 36 · see citing works

Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management

Wojtara, M., Mazumder, A., Syeda, Y., & Mozgała, N. (2023) · Advances in Medicine · doi:10.1155/2023/9946924 · Cited by 36 · see citing works

Downregulation of miR-139-5p contributes to the antiapoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1

Li, J., Su, L., Gong, Y., Ding, M., Hong, S., Yu, S., & Xiao, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173576 · Cited by 35 · see citing works

The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease

Ravarotto, V., Bertoldi, G., Innico, G., Gobbi, L., & Calò, L. A. (2021) · Antioxidants · doi:10.3390/antiox10071041 · Cited by 35 · see citing works

Long-Wavelength Ratiometric Fluorescent Probe for the Early Diagnosis of Diabetes

Wang, J., Zhang, L., Qu, Y., Yang, Y., Cao, T., Cao, Y., Iqbal, A., Qin, W., & Liu, Y. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01491 · Cited by 35 · see citing works

Impact of treatment with saxagliptin on glycaemic stability and β‐cell function in the SAVOR‐TIMI 53 study

Leibowitz, G., Cahn, A., Bhatt, D. L., Hirshberg, B., Mosenzon, O., Wei, C., Jermendy, G., Sheu, W. H., Sendon, J. L., Im, K., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12445 · Cited by 34 · see citing works

p38β Mitogen-Activated Protein Kinase Signaling Mediates Exenatide-Stimulated Microglial β-Endorphin Expression

Wu, H., Mao, X.-F., Fan, H. J., & Wang, Y. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107102 · Cited by 34 · see citing works

Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats

Yin, W., Jiang, Y., Xu, S., Wang, Z., Peng, L., Fang, Q., Deng, T., Zhao, W., Zhang, W., & Lou, J. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12956 · Cited by 33 · see citing works

Diabetes and Cardiovascular Risk in Renal Transplant Patients

Rysz, J., Franczyk, B., Radek, M., Ciałkowska-Rysz, A. D., & Gluba-Brzózka, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073422 · Cited by 34 · see citing works

Adults with long‐duration type 2 diabetes have blunted glycemic and β‐Cell function improvements after bariatric surgery

Khanna, V., Malin, S. K., Bena, J., Abood, B., Pothier, C. E., Bhatt, D. L., Nissen, S. E., Watanabe, R. M., Brethauer, S. A., Schauer, P. R., et al. (2015) · Obesity · doi:10.1002/oby.21021 · Cited by 33 · see citing works

Perspectives on evaluating health effects of starch: Beyond postprandial glycemic response

Kong, H., Yu, L., Li, C., Ban, X., Gu, Z., Liu, L., & Li, Z. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119621 · Cited by 33 · see citing works

Big peptide drugs in a small molecule world

Otvos, L. J., & Wade, J. D. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1302169 · Cited by 33 · see citing works

Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway

Ding, M., Fang, Q., Cui, Y., Shen, Q.-L., Liu, Q., Wang, P., Yu, D. M., & Li, C. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.12.013 · Cited by 33 · see citing works

Mechanism of glucagon-like peptide 1 improvements in type 2 diabetes mellitus and obesity.

Nolen-Doerr, E., Stockman, M.-C., & Rizo, I. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00350-4 · Cited by 32 · see citing works

Antidiabetic potential of fenugreek ( Trigonella foenum‐graecum ): A magic herb for diabetes mellitus

Sarker, D. K., Ray, P., Dutta, A. K., Rouf, R., & Uddin, S. J. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4440 · Cited by 32 · see citing works

Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study

Nakhla, M., Nair, A. V., Balani, P., Ujjawal, A., Kumar, P. A., Dasari, M., Yukselen, Z., Bansal, K., Ganatra, S., & Dani, S. S. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07613-w · Cited by 32 · see citing works

Effects of carbohydrate restriction on postprandial glucose metabolism, β-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes

Skytte, M. J., Samkani, A., Astrup, A. V., Frystyk, J., Rehfeld, J. F., Holst, J. J., Madsbad, S., Burling, K., Fenger, M., Thomsen, M. N., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2020 · Cited by 32 · see citing works

Obesity in children and adolescents: Overview of the diagnosis and management

Tung, J. Y., Poon, G. W.-K., Du, J., & Wong, K. K. (2023) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.58 · Cited by 33 · see citing works

Exendin-4 increases oxygen consumption and thermogenic gene expression in muscle cells

Choung, J.-S., Lee, Y.-S., & Jun, H.-S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0078 · Cited by 31 · see citing works

Current Perspectives on Management of Type 2 Diabetes in Youth

Singhal, S., & Kumar, S. (2021) · Children · doi:10.3390/children8010037 · Cited by 32 · see citing works

Assessment of the potential of temporin peptides from the frog Rana temporaria (Ranidae) as anti‐diabetic agents

Musale, V., Casciaro, B., Mangoni, M. L., Abdel‐Wahab, Y. H. A., Flatt, P. R., & Conlon, J. M. (2018) · Journal of Peptide Science · doi:10.1002/psc.3065 · Cited by 30 · see citing works

Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists

Kelly, C. A., & Sipos, J. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae722 · Cited by 30 · see citing works

Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future

Pinheiro, M. M., Pinheiro, F. M. M., & Trabachin, M. L. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.02.003 · Cited by 29 · see citing works

Novel GLP-1 Analog Supaglutide Stimulates Insulin Secretion in Mouse and Human Islet Beta-Cells and Improves Glucose Homeostasis in Diabetic Mice

Ren, L., Cui, Q., Liu, W., Wang, L., Liao, Y., Feng, Y., Sun, W., Yang, Y., Zhang, Z., Jin, T., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00930 · Cited by 28 · see citing works

Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients

Correale, M., Lamacchia, O., Ciccarelli, M., Dattilo, G., Tricarico, L., & Brunetti, N. D. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10157-y · Cited by 29 · see citing works

Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)

Tilinca, M. C., Tiucă, R. A., Niculas, C., Varga, A., & Ţilea, I. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10601 · Cited by 30 · see citing works

Combined effect of GABA and glucagon‐like peptide‐1 receptor agonist on cytokine‐induced apoptosis in pancreatic β‐cell line and isolated human islets

Son, D. O., Liu, W., Li, X., Prud’homme, G. J., & Wang, Q. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12881 · Cited by 28 · see citing works

Glucagon‐like peptide 1‐potentiated insulin secretion and proliferation of pancreatic β‐cells GLP‐1促进胰岛素分泌和胰岛β细胞增殖的机制

Ma, X., Guan, Y., & Hua, X. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12161 · Cited by 34 · see citing works

Effect of glucagon-like peptide-1 on pancreatic β-cells

An, R. (2009) · International Journal of Pathology and Clinical Medicine

Glucagon‐like peptide‐1: modulator of <i>β</i> ‐cell dysfunction and death

Rondas, D., D'Hertog, W., Overbergh, L., & Mathieu, C. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12165 · Cited by 32 · see citing works

New insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells

Xiong, X., Shao, W., & Jin, T. (2012) · Islets · doi:10.4161/isl.23345 · Cited by 27 · see citing works

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells

Caporarello, N., Parrino, C., Trischitta, V., & Frittitta, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181190 · Cited by 11 · see citing works